Chemical Compound

Gynostemma Extract

CAS Registry Number 80321-63-7
Gynostemma Extract chemical structure
Primary Record

Gynostemma Extract

Note: Only for scientific research or as raw materials for production.

In stock
2,915 g
Purity
98.8 %
CAS
80321-63-7

Compound Identifiers & Properties

CAS
80321-63-7
PubChem CID
46887681
SMILES
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)O)O)O)O)C
Canonical SMILES
CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@]12C

Names & Synonyms

  • Gynostemma Extract
  • Gypenoside IX
  • Notoginsenoside Fd
  • Gynosaponin I
  • Gynosaponin S
  • STEVENLEAF
  • ginsenoside C-Mx1
  • Gynostemma-Extract
  • Gisenoside C-Mx1
  • 80321-63-7
  • GYPENOSIDEIX
  • RefChem:922652
  • DTXSID001317599
  • orb1300690
  • CHEMBL1095009
  • SCHEMBL29580076
  • DTXCID001747405
  • HY-N0167
  • BDBM50317535
  • C47H80O17
  • NP7053
  • s2306
  • AKOS022168210
  • ZINC245240534
  • ACN-046871
  • CCG-270573
  • CS-5342
  • EBC-616201
  • OG44044
  • C47-H80-O17
  • NCGC00386168-01
  • AC-34770
  • DA-67789
  • MS-31714
  • S844
  • B3666
  • FT-0696323
  • FT-0777286
  • J2.870.413E
  • Ginsenoside C-Mx1; Gynosaponin I; Gypenoside IX
  • BRD-K58775955-001-02-4
  • Ginsenoside C-Mx1;Gynosaponin I;Gypenoside IX;Notoginsenoside Fd
  • (2S,3R,4S,5S,6R)-2-{[(2S)-2-[(1S,3aR,3bR,5aR,7S,9aR,9bR,11R,11aR)-11-hydroxy-3a,3b,6,6,9a-pentamethyl-7-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-en-2-yl]oxy}-6-({[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
  • (1R)-1-[(8xi,9xi,12alpha,13xi,14beta)-3-(beta-D-glucopyranosyloxy)-12-hydroxy-4,4,10,14-tetramethylgonan-17-yl]-1,5-dimethylhex-4-en-1-yl 6-O-(2-O-methyl-beta-D-xylopyranosyl)-beta-D-allopyranoside
  • (2R,3R,4S,5S,6R)-2-{[(1S,3aR,3bR,5aR,7S,9aR,9bR,11R,11aR)-11-hydroxy-3a,3b,6,6,9a-pentamethyl-1-[(2S)-6-methyl-2-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}hept-5-en-2-yl]-dodecahydro-1H-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
  • (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol
  • 12beta-Hydroxy-20-[(6-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy]dammar-24-en-3beta-yl beta-D-glucopyranoside
  • 2-(hydroxymethyl)-6-[[12-hydroxy-4,4,8,10,14-pentamethyl-17-[6-methyl-2-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol
  • 3-O-|A-D-Glucopyranosyl-20-O-<|A-L-arabinopyranosyl(1->6)-|A-D-glucopyranosyl>-20(S)-protopanaxadiol
  • 3beta-(beta-D-Glucopyranosyloxy)-20-[6-O-(beta-D-xylopyranosyl)-beta-D-glucopyranosyloxy]dammara-24-ene-12beta-ol
  • 3beta-[(beta-D-Glucopyranosyl)oxy]-12beta-hydroxy-5alpha-dammara-24-ene-20-yl 6-O-(beta-D-xylopyranosyl)-beta-D-glucopyranoside
  • SS-D-GLUCOPYRANOSIDE, (3SS,12SS)-3-(SS-D-GLUCOPYRANOSYLOXY)-12-HYDROXYDAMMAR-24-EN-20-YL 6-O-SS-D-XYLOPYRANOSYL-